Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 44 out of 100. Digital health tools

Topic: Risk, prevention and care in population studies

The prevalence of dementia is growing worldwide due to the fast ageing of the population. Dementia is an intricate illness that is frequently produced by a mixture of genetic and environmental risk factors. There is no treatment for dementia yet; therefore, the early detection and identification of persons at greater risk of emerging dementia becomes crucial, as this might deliver an opportunity to adopt lifestyle variations to decrease the risk of dementia. Many dementia risk prediction techniques to recognize individuals at high risk have progressed in the past few years. Accepting a structure uniting explainability in artificial intelligence (XAI) with intricate systems will enable us to classify analysts of dementia incidence and then verify their occurrence in the survey as recognized or suspected risk factors. Deep learning (DL) and machine learning (ML) are current techniques for detecting and classifying dementia and making decisions without human participation. This study introduces a Leveraging Explainability Artificial Intelligence and Optimization Algorithm for Accurate Dementia Prediction and Classification Model (LXAIOA-ADPCM) technique in medical diagnosis. The main intention of the LXAIOA-ADPCM technique is to progress a novel algorithm for dementia prediction using advanced techniques. Initially, data normalization is performed by utilizing min-max normalization to convert input data into a beneficial format. Furthermore, the feature selection process is performed by implementing the naked mole-rat algorithm (NMRA) model. For the classification process, the proposed LXAIOA-ADPCM model implements ensemble classifiers such as the bidirectional long short-term memory (BiLSTM), sparse autoencoder (SAE), and temporal convolutional network (TCN) techniques. Finally, the hyperparameter selection of ensemble models is accomplished by utilizing the gazelle optimization algorithm (GOA) technique. Finally, the Grad-CAM is employed as an XAI technique to enhance transparency by providing human-understandable insights into their decision-making processes. A broad array of experiments using the LXAIOA-ADPCM technique is performed under the Dementia Prediction dataset. The simulation validation of the LXAIOA-ADPCM technique portrayed a superior accuracy output of 95.71% over existing models.

Key findings

Why it matters

This paper proposes a deep learning and explainable artificial intelligence model for predicting and classifying dementia to support clinical decisions. It reports no tested treatment, cure, or prevention.

Study details

How this study scored 44/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 2 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 2 of 7; Citations per year 2 of 5; Impact for its field and year 3 of 6; Cited by studies here 1 of 6; Still being cited 1 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 42 of the 96 points it could be judged on, which is 44 of 100. Total 44 of 100.42 of the 96 points we could judge = 44 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 42 of the 96 points we could judge it on, which is 44 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Scientific Reports)
Journal's citation record 3 / 4 Scientific Reports: journal h-index 463 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 2 / 7 Cited 10 times (OpenAlex, 2026-10-10)
Citations per year 2 / 5 3.3 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 7.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 1 / 4 Cited 10 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record 0 / 3 King Khalid University: institution h-index 220 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 8 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40360623)
Free to read 2 / 2 Free to read
Points 42 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 42 of the 96 points we could judge it on is 44 out of 100.
Total 44 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Medani, M., Elhessewi, G. M. S., Alqahtani, M. A., ASKLANY, S. A., Alamro, S., Albalawneh, D., et al. (2025). Leveraging explainable artificial intelligence with ensemble of deep learning model for dementia prediction to enhance clinical decision support systems. Scientific Reports. https://doi.org/10.1038/s41598-025-97102-3

Vancouver

Medani M, Elhessewi GMS, Alqahtani MA, ASKLANY SA, Alamro S, Albalawneh D, et al. Leveraging explainable artificial intelligence with ensemble of deep learning model for dementia prediction to enhance clinical decision support systems. Scientific Reports. 2025. doi:10.1038/s41598-025-97102-3. PMID: 40360623.

BibTeX

@article{medani2025-40360623,
  author  = {Medani, Mohamed and Elhessewi, Ghada Moh. Samir and Alqahtani, Mohammed Abdulrahman and ASKLANY, SOMIA A. and Alamro, Sulaiman and Albalawneh, Da’ad and Alshammeri, Menwa and Assiri, Mohammed Abdullah},
  title   = {{Leveraging explainable artificial intelligence with ensemble of deep learning model for dementia prediction to enhance clinical decision support systems}},
  journal = {Scientific Reports},
  year    = {2025},
  doi     = {10.1038/s41598-025-97102-3},
  pmid    = {40360623},
  url     = {https://doi.org/10.1038/s41598-025-97102-3}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Digital health tools

Similar studies

More on Digital health tools

See all studies in Digital health tools →